Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value: $952M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 4,639,413 | $82.67M | 8.7% | — | — | COM | N5749R100 |
| — | SPRINGWORKS THERAPEUTICS INC | 2,844,145 | $61.66M | 6.5% | — | — | COM | 85205L107 |
| IONS | IONIS PHARMACEUTICALS INC | 935,548 | $56.05M | 5.9% | — | — | COM | 462222100 |
| ACIU | AC IMMUNE SA | 11,297,911 | $55.92M | 5.9% | — | — | SHS | H00263105 |
| CYTK | CYTOKINETICS INC | 4,165,558 | $47.4M | 5.0% | — | — | COM NEW | 23282W605 |
| GLPG | GALAPAGOS NV | 305,076 | $46.57M | 4.9% | — | — | SPON ADR | 36315X101 |
| XOMA | XOMA CORP DEL | 1,796,942 | $35.08M | 3.7% | — | — | COM NEW | 98419J206 |
| RCUS | ARCUS BIOSCIENCES INC | 3,579,023 | $32.57M | 3.4% | — | — | COM | 03969F109 |
| — | BLUEPRINT MEDICINES CORP | 437,565 | $32.15M | 3.4% | — | — | COM | 09627Y109 |
| — | GLYCOMIMETICS INC | 7,361,801 | $31.73M | 3.3% | — | — | COM | 38000Q102 |
| KURA | KURA ONCOLOGY INC | 1,998,276 | $30.31M | 3.2% | — | — | COM | 50127T109 |
| REPL | REPLIMUNE GROUP INC | 1,749,709 | $24.32M | 2.6% | — | — | COM | 76029N106 |
| — | DECIPHERA PHARMACEUTICALS INC | 710,697 | $24.12M | 2.5% | — | — | COM | 24344T101 |
| — | MIRATI THERAPEUTICS INC | 308,984 | $24.07M | 2.5% | — | — | COM | 60468T105 |
| — | MOLECULAR TEMPLATES INC | 3,380,604 | $22.28M | 2.3% | — | — | COM | 608550109 |
| — | CALITHERA BIOSCIENCES INC | 6,750,482 | $20.86M | 2.2% | — | — | COM | 13089P101 |
| — | PIERIS PHARMACEUTICALS INC | 5,349,905 | $18.24M | 1.9% | — | — | COM | 720795103 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $17.95M | 1.9% | — | — | COM | 45665G303 |
| — | DICERNA PHARMACEUTICALS INC | 1,223,925 | $17.58M | 1.8% | — | — | COM | 253031108 |
| XENE | XENON PHARMACEUTICALS INC | 1,741,600 | $15.69M | 1.6% | — | — | COM | 98420N105 |
| — | ARQULE INC | 2,108,662 | $15.12M | 1.6% | — | — | COM | 04269E107 |
| — | FIVE PRIME THERAPEUTICS INC | 3,765,168 | $14.59M | 1.5% | — | — | COM | 33830X104 |
| CTMX | CYTOMX THERAPEUTICS INC | 1,877,148 | $13.85M | 1.5% | — | — | COM | 23284F105 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,764,784 | $13.18M | 1.4% | — | — | COM | 87164F105 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,441,429 | $12.97M | 1.4% | — | — | COM | 45166A102 |
| ANAB | ANAPTYSBIO INC | 353,818 | $12.38M | 1.3% | — | — | COM | 032724106 |
| — | AKERO THERAPEUTICS INC | 471,746 | $10.73M | 1.1% | — | — | COM | 00973Y108 |
| SPRO | SPERO THERAPEUTICS INC | 939,704 | $9.961M | 1.0% | — | — | COM | 84833T103 |
| — | CHEMOCENTRYX INC | 1,414,515 | $9.59M | 1.0% | — | — | COM | 16383L106 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,047,155 | $9.172M | 1.0% | — | — | COM | 221015100 |
| — | ESSA PHARMA INC | 2,640,565 | $8.899M | 0.9% | — | — | COM NEW | 29668H708 |
| — | GALMED PHARMACEUTICALS LTD | 1,832,484 | $8.759M | 0.9% | — | — | SHS | M47238106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 682,630 | $8.198M | 0.9% | — | — | COM | 74366E102 |
| — | PREVAIL THERAPEUTICS INC | 656,483 | $8.062M | 0.8% | — | — | COM | 74140Y101 |
| — | VERASTEM INC | 6,328,994 | $7.658M | 0.8% | — | — | COM | 92337C104 |
| — | X4 PHARMACEUTICALS INC | 593,474 | $7.543M | 0.8% | — | — | COM | 98420X103 |
| OVID | OVID THERAPEUTICS INC | 2,321,236 | $7.521M | 0.8% | — | — | COM | 690469101 |
| — | FORWARD PHARMA A/S | 6,480,079 | $6.61M | 0.7% | — | — | SPONSORED ADS | 34986J105 |
| — | MERSANA THERAPEUTICS INC | 4,041,888 | $6.386M | 0.7% | — | — | COM | 59045L106 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 2,100,305 | $6.091M | 0.6% | — | — | COM NEW | 372427401 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $5.766M | 0.6% | — | — | COM | 12648L601 |
| — | EIGER BIOPHARMACEUTICALS INC | 539,512 | $5.53M | 0.6% | — | — | COM | 28249U105 |
| — | CIDARA THERAPEUTICS INC | 2,687,738 | $5.362M | 0.6% | — | — | COM | 171757107 |
| — | SPRING BK PHARMACEUTICALS INC | 1,378,841 | $4.826M | 0.5% | — | — | COM | 849431101 |
| — | BIOLINERX LTD | 1,733,036 | $4.575M | 0.5% | — | — | SPONSORED ADS | 09071M205 |
| — | ALPINE IMMUNE SCIENCES INC | 1,137,764 | $4.46M | 0.5% | — | — | COM | 02083G100 |
| — | SUNESIS PHARMACEUTICALS INC | 6,194,925 | $4.46M | 0.5% | — | — | COM | 867328700 |
| — | GAMIDA CELL LTD | 1,000,000 | $4.33M | 0.5% | — | — | SHS | M47364100 |
| — | MEI PHARMA INC | 2,221,272 | $3.732M | 0.4% | — | — | COM NEW | 55279B202 |
| — | SUTRO BIOPHARMA INC | 344,196 | $3.129M | 0.3% | — | — | COM | 869367102 |
| — | ERYTECH PHARMA | 625,000 | $2.775M | 0.3% | — | — | SPONSORED ADR | 29604W108 |
| — | SURFACE ONCOLOGY INC | 1,086,251 | $1.542M | 0.2% | — | — | COM | 86877M209 |
| MREO | MEREO BIOPHARMA GROUP PLC | 523,382 | $1.518M | 0.2% | — | — | ADS | 589492107 |
| — | REGULUS THERAPEUTICS INC | 2,035,695 | $1.466M | 0.2% | — | — | COM NEW | 75915K200 |
| — | ADURO BIOTECH INC | 1,010,000 | $1.071M | 0.1% | — | — | COM | 00739L101 |
| — | BRICKELL BIOTECH INC | 228,093 | $947K | 0.1% | — | — | COM | 10802T105 |
| — | CONTRAFECT CORP | 1,898,990 | $680K | 0.1% | — | — | COM | 212326102 |
| — | ALBIREO PHARMA INC | 29,000 | $580K | 0.1% | — | — | COM | 01345P106 |
| — | NOVUS THERAPEUTICS INC | 828,876 | $522K | 0.1% | — | — | COM | 67011N105 |